# Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)

> **NCT00988520** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 38 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Rocuronium bromide
- **DRUG:** Rocuronium bromide
- **DRUG:** Rocuronium bromide
- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT00988520
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00988520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00988520, "Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00988520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*